LIGAND PHARMACEUTICALS INC ($LGND)
Filing Information
| Accession Number | 0002001011-26-000046 |
|---|---|
| Form Type | 4 |
| Filing Date | May 5, 2026 |
| Document | View SEC Filing |
Transactions
9
Total Shares
15,000
Total Value
$1,417,905.60
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CLO & Secretary | Common Stock | โ | May 1, 2026 | Exercise/Conversion | 5,000 | $52.27 | $261,350.00 | 46,382 | Direct | โ | View Details | |
CLO & Secretary | Common Stock | โ | May 1, 2026 | Sale | 600 | $227.45 | $136,469.58 | 45,782 | Direct | โ | View Details | |
CLO & Secretary | Common Stock | โ | May 1, 2026 | Sale | 932 | $228.75 | $213,198.45 | 44,850 | Direct | โ | View Details | |
CLO & Secretary | Common Stock | โ | May 1, 2026 | Sale | 98 | $229.71 | $22,511.44 | 44,752 | Direct | โ | View Details | |
CLO & Secretary | Common Stock | โ | May 1, 2026 | Sale | 370 | $230.87 | $85,421.60 | 44,382 | Direct | โ | View Details | |
CLO & Secretary | Common Stock | โ | May 1, 2026 | Sale | 780 | $232.04 | $180,991.12 | 43,602 | Direct | โ | View Details | |
CLO & Secretary | Common Stock | โ | May 1, 2026 | Sale | 1,420 | $232.92 | $330,749.24 | 42,182 | Direct | โ | View Details | |
CLO & Secretary | Common Stock | โ | May 1, 2026 | Sale | 800 | $234.02 | $187,214.16 | 41,382 | Direct | โ | View Details | |
CLO & Secretary | Employee Stock Option (right to buy) | Derivative | May 1, 2026 | Exercise/Conversion | 5,000 | $0.00 | $0.00 | 44,444 | Direct | โ | View Details |